Top Markets
#1 Velas Velas +562.78%
#2 Polymath Polymath +529.94%
#3 Galxe Galxe +96.05%
#4 XION XION +63.34%
#5 Resolv wstUSR Resolv wstUSR +59.11%
#6 Nomina Nomina +45.78%
#7 Cofinex Cofinex +26.87%
#8 Swarms Swarms +16.74%
#9 Unibase Unibase +15.72%
#10 Cysic Cysic +14.51%
Coin of the day
Velas Velas
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Exscientia plc Exscientia plc

Exscientia plc

EXAI
Rang in aandelen #99999
Exscientia plc, an artificial intelligence-driven pharmatech company, engages... Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
Aandeelprijs
$4.84
Marktkapitalisatie
$633.18M
Verandering (1 dag)
3.20%
Verandering (1 jaar)
0.00%
Land
GB
Handel Exscientia plc (EXAI)

Categorie

Healthcare
EPS voor Exscientia plc (EXAI)
EPS per September 2024 TTM: $-1.61
Volgens de laatste financiële rapporten en de aandelenkoers van Exscientia plc is de huidige EPS van het bedrijf (TTM) $-1.61. Eind 2022 had het bedrijf een EPS van $-1.16, een stijging ten opzichte van de EPS van 2021 die $-0.41 bedroeg.
EPS-geschiedenis van Exscientia plc van 2019 tot 2026
EPS aan het einde van elk jaar
Jaar EPS Wijzigen
2026 (TTM) $-1.61 7.05%
2023 $-1.50 29.34%
2022 $-1.16 186.34%
2021 $-0.41 18.67%
2020 $-0.34 274.78%
2019 $-0.09 0.00%
EPS van vergelijkbare bedrijven of concurrenten
Bedrijf EPS EPS-verschil Land
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 $3.62 -325.59%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $15.47 -1,063.44%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $43.12 -2,785.43%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $9.62 -699.17%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $2.98 -285.59%
AU